Listen
TROMBOVAR
-
Opinions on drugs -
Posted on
Jun 06 2012
- Updated on
Jun 22 2012
Reason for request
Re-evaluation of the actual benefit following an initiative by the transparency Committee as provided for by Article R 163-21 of the Social Security Code, renewal of inclusion on the list of proprietary medicinal products refundable by National Health Insurance and changes to the Summary of Product Characteristics.
-
Clinical Benefit
| Moderate |
The actual benefit of TROMBOVAR remains moderate. |
Contact Us
Évaluation des médicaments
